Additionally, understanding the protective mechanisms of TIF1-γ against pulmonary fibrosis could lead to novel therapeutic strategies not only for JDM but also for other fibrotic lung diseases. This evidence concerns the gene TRIM33 and juvenile dermatomyositis.